NASDAQ:SILK Silk Road Medical (SILK) Stock Price, News & Analysis → What’s Really Next for America… (From Porter & Company) (Ad) Free SILK Stock Alerts $20.72 -0.31 (-1.47%) (As of 05/13/2024 ET) Add Compare Share Share Today's Range$20.59▼$21.4750-Day Range$15.48▼$21.0352-Week Range$6.08▼$34.94Volume384,389 shsAverage Volume775,380 shsMarket Capitalization$817.20 millionP/E RatioN/ADividend YieldN/APrice Target$22.55 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Get Silk Road Medical alerts: Email Address Silk Road Medical MarketRank™ Stock AnalysisAnalyst RatingHold2.18 Rating ScoreUpside/Downside8.8% Upside$22.55 Price TargetShort InterestBearish10.34% of Shares Sold ShortDividend StrengthN/ASustainability-0.74Upright™ Environmental ScoreNews SentimentN/AInsider TradingSelling Shares$351,247 Sold Last QuarterProj. Earnings GrowthGrowingFrom ($1.43) to ($1.34) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.29 out of 5 starsMedical Sector1605th out of 2,771 stocksSurgical & Medical Instruments Industry187th out of 300 stocks 1.1 Analyst's Opinion Consensus RatingSilk Road Medical has received a consensus rating of Hold. The company's average rating score is 2.18, and is based on 4 buy ratings, 5 hold ratings, and 2 sell ratings.Amount of Analyst CoverageSilk Road Medical has only been the subject of 4 research reports in the past 90 days.Read more about Silk Road Medical's stock forecast and price target. Previous Next 2.0 Short Interest Percentage of Shares Shorted10.34% of the outstanding shares of Silk Road Medical have been sold short.Short Interest Ratio / Days to CoverSilk Road Medical has a short interest ratio ("days to cover") of 5.5.Change versus previous monthShort interest in Silk Road Medical has recently decreased by 1.45%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldSilk Road Medical does not currently pay a dividend.Dividend GrowthSilk Road Medical does not have a long track record of dividend growth. Previous Next 4.3 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreSilk Road Medical has received a 62.88% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is driven by its "Surgical instruments" and "Medical devices engineering" products. See details.Environmental SustainabilityThe Environmental Impact score for Silk Road Medical is -0.74. Previous Next 3.0 News and Social Media Coverage News SentimentSilk Road Medical has a news sentiment score of 1.45. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.57 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Silk Road Medical this week, compared to 3 articles on an average week.Search InterestOnly 1 people have searched for SILK on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat Follows1 people have added Silk Road Medical to their MarketBeat watchlist in the last 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Silk Road Medical insiders have sold 76.70% more of their company's stock than they have bought. Specifically, they have bought $198,783.00 in company stock and sold $351,247.00 in company stock.Percentage Held by InsidersOnly 6.70% of the stock of Silk Road Medical is held by insiders.Read more about Silk Road Medical's insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Silk Road Medical are expected to grow in the coming year, from ($1.43) to ($1.34) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Silk Road Medical is -15.12, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Silk Road Medical is -15.12, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioSilk Road Medical has a P/B Ratio of 5.34. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Silk Road Medical's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Porter & CompanyGuard Against the Coming Financial UpheavalAmerica’s Most Shocking Financial Story… Behind closed doors in D.C., there is a dark political and economic plot underway. That’s why if you have any savings in the bank or own any assets you want to protect, you must watch this new documentary before it’s too late.You can stream it for free right here. About Silk Road Medical Stock (NASDAQ:SILK)Silk Road Medical, Inc operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization (TCAR). Its products comprise ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and establish temporary blood flow reversal; ENROUTE Transcarotid Stent System for transcarotid access; ENHANCE Transcarotid Peripheral Access Kit, which is used to gain initial access to the common carotid artery; ENROUTE 0.014 Guidewire for atraumatic vessel navigation and target lesion crossing for delivery of interventional devices; and ENROUTE Enflate Transcarotid RX Balloon Dilation Catheter, a transcarotid rapid exchange balloon for the TCAR procedure. The company was incorporated in 2007 and is headquartered in Sunnyvale, California.Read More SILK Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SILK Stock News HeadlinesMay 7, 2024 | americanbankingnews.comSilk Road Medical, Inc (NASDAQ:SILK) Given Average Recommendation of "Hold" by AnalystsMay 4, 2024 | americanbankingnews.comJPMorgan Chase & Co. Boosts Silk Road Medical (NASDAQ:SILK) Price Target to $21.00May 4, 2024 | americanbankingnews.comPiper Sandler Raises Silk Road Medical (NASDAQ:SILK) Price Target to $20.00May 2, 2024 | finance.yahoo.comSilk Road Medical, Inc (NASDAQ:SILK) Q1 2024 Earnings Call TranscriptMay 2, 2024 | finance.yahoo.comSilk Road Medical First Quarter 2024 Earnings: Beats ExpectationsMay 1, 2024 | markets.businessinsider.comOppenheimer Reaffirms Their Buy Rating on Silk Road Medical (SILK)May 1, 2024 | msn.comSILK Stock Earnings: Silk Road Medical Beats EPS, Beats Revenue for Q1 2024May 1, 2024 | markets.businessinsider.comEvaluating Silk Road Medical: Insights From 6 Financial AnalystsMay 1, 2024 | bbc.co.ukCrossing Continents - Cleansing Turkey - BBC SoundsMay 1, 2024 | finance.yahoo.comSilk Road Medical Inc (SILK) Q1 2024 Earnings Call Transcript Highlights: Navigating Growth ...May 1, 2024 | msn.comAustralia news live: Justice Lee criticises Ten lawyer over claims Lehrmann defamation judgment was ‘divorced from reality’April 30, 2024 | sfgate.comSilk Road Medical: Q1 Earnings SnapshotApril 30, 2024 | finance.yahoo.comSilk Road Medical Reports First Quarter 2024 Financial ResultsApril 30, 2024 | finance.yahoo.comSilk Road Medical Inc (SILK) Q1 2024 Earnings: Revenue Surpasses Expectations, Losses NarrowApril 29, 2024 | markets.businessinsider.comLake Street Keeps Their Buy Rating on Silk Road Medical (SILK)April 23, 2024 | globenewswire.comSilk Road Medical to Present at the BofA Securities 2024 Healthcare ConferenceApril 9, 2024 | globenewswire.comSilk Road Medical to Report First Quarter 2024 Financial Results on April 30, 2024April 5, 2024 | msn.comTaiwan Earthquake: What to Know About Travel and How to HelpApril 3, 2024 | finance.yahoo.comWorker injured by electric shock from power line in BiddefordApril 3, 2024 | msn.comAncient People Also Had Sunburns, So They Used These 4 Forms of ProtectionApril 2, 2024 | globenewswire.comSilk Road Medical Strengthens TCAR Portfolio with Launch of ENROUTE Transcarotid Neuroprotection System PLUSMarch 28, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: PAVmed (PAVM) and Simulations Plus (SLP)March 15, 2024 | finance.yahoo.comSILK Oct 2024 25.000 callMarch 15, 2024 | finance.yahoo.comSILK Jul 2024 25.000 callMarch 11, 2024 | yahoo.comWhy now’s the time to discover Uzbekistan – before it turns into DubaiSee More Headlines Receive SILK Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Silk Road Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings4/30/2024Today5/14/2024Next Earnings (Estimated)8/06/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNASDAQ:SILK CUSIPN/A CIK1397702 Webwww.silkroadmed.com Phone(408) 720-9002Fax408-720-9013Employees474Year FoundedN/APrice Target and Rating Average Stock Price Target$22.55 High Stock Price Target$47.00 Low Stock Price Target$8.00 Potential Upside/Downside+8.8%Consensus RatingHold Rating Score (0-4)2.18 Research Coverage11 Analysts Profitability EPS (Most Recent Fiscal Year)($1.37) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-55,740,000.00 Net Margins-29.02% Pretax Margin-28.80% Return on Equity-35.47% Return on Assets-20.67% Debt Debt-to-Equity Ratio0.52 Current Ratio11.05 Quick Ratio9.62 Sales & Book Value Annual Sales$177.13 million Price / Sales4.61 Cash FlowN/A Price / Cash FlowN/A Book Value$3.88 per share Price / Book5.34Miscellaneous Outstanding Shares39,440,000Free Float36,801,000Market Cap$817.20 million OptionableOptionable Beta1.43 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleGrowth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.Get This Free Report Key ExecutivesMr. Lucas W. Buchanan (Age 46)CFO & COO Comp: $870.55kMr. Kevin M. Klemz (Age 63)EVP, Chief Legal Officer & Secretary Comp: $644.12kMr. Andrew S. Davis (Age 55)Chief Commercial Officer Comp: $836.33kMr. Richard M. Ruedy (Age 57)Executive Vice President of Clinical, Regulatory Affairs & Quality Assurance Comp: $542.41kMr. Charles S. McKhann (Age 55)Chief Executive Officer Ms. Mhairi L. Jones (Age 53)Chief Accounting Officer & VP of Finance Ms. Tammy LeitsingerCompliance Officer & VP of Medical AffairsMr. Jorge O'HaraVice President of Marketing, Business Development & StrategyMs. Alison HighlanderVice President of Human ResourcesDr. Sumaira MacDonald M.D.Ph.D., Executive Medical DirectorMore ExecutivesKey CompetitorsOrthoPediatricsNASDAQ:KIDSCardiovascular SystemsNASDAQ:CSIIParagon 28NYSE:FNAAtrionNASDAQ:ATRITreace Medical ConceptsNASDAQ:TMCIView All CompetitorsInsiders & InstitutionsVanguard Group Inc.Bought 30,726 shares on 5/10/2024Ownership: 7.410%Acadian Asset Management LLCSold 157,777 shares on 5/10/2024Ownership: 0.429%First Eagle Investment Management LLCBought 87,595 shares on 5/9/2024Ownership: 0.222%State Board of Administration of Florida Retirement SystemBought 1,090 shares on 5/9/2024Ownership: 0.031%Russell Investments Group Ltd.Bought 44,647 shares on 5/8/2024Ownership: 0.114%View All Insider TransactionsView All Institutional Transactions SILK Stock Analysis - Frequently Asked Questions Should I buy or sell Silk Road Medical stock right now? 11 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Silk Road Medical in the last year. There are currently 2 sell ratings, 5 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" SILK shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SILK, but not buy additional shares or sell existing shares. View SILK analyst ratings or view top-rated stocks. What is Silk Road Medical's stock price target for 2024? 11 brokers have issued 12 month price objectives for Silk Road Medical's shares. Their SILK share price targets range from $8.00 to $47.00. On average, they expect the company's share price to reach $22.55 in the next year. This suggests a possible upside of 8.8% from the stock's current price. View analysts price targets for SILK or view top-rated stocks among Wall Street analysts. How have SILK shares performed in 2024? Silk Road Medical's stock was trading at $12.27 at the beginning of 2024. Since then, SILK stock has increased by 68.9% and is now trading at $20.72. View the best growth stocks for 2024 here. When is Silk Road Medical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 6th 2024. View our SILK earnings forecast. How were Silk Road Medical's earnings last quarter? Silk Road Medical, Inc (NASDAQ:SILK) issued its quarterly earnings results on Tuesday, April, 30th. The company reported ($0.36) earnings per share for the quarter, beating analysts' consensus estimates of ($0.40) by $0.04. The business earned $48.50 million during the quarter, compared to analyst estimates of $44.67 million. Silk Road Medical had a negative trailing twelve-month return on equity of 35.47% and a negative net margin of 29.02%. The company's quarterly revenue was up 20.9% on a year-over-year basis. During the same quarter last year, the firm earned ($0.43) EPS. What ETFs hold Silk Road Medical's stock? ETFs with the largest weight of Silk Road Medical (NASDAQ:SILK) stock in their portfolio include SPDR S&P Health Care Equipment ETF (XHE) and Invesco Dorsey Wright Healthcare Momentum ETF (PTH).iShares U.S. Medical Devices ETF (IHI). What guidance has Silk Road Medical issued on next quarter's earnings? Silk Road Medical updated its FY 2024 earnings guidance on Tuesday, April, 30th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $194.0 million-$198.0 million, compared to the consensus revenue estimate of $195.9 million. What other stocks do shareholders of Silk Road Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Silk Road Medical investors own include RTX (RTX), Procter & Gamble (PG), Abbott Laboratories (ABT), Cisco Systems (CSCO), Pfizer (PFE), Edwards Lifesciences (EW), CSX (CSX), Thermo Fisher Scientific (TMO) and Alibaba Group (BABA). When did Silk Road Medical IPO? Silk Road Medical (SILK) raised $75 million in an initial public offering (IPO) on Thursday, April 4th 2019. The company issued 4,700,000 shares at $15.00-$17.00 per share. J.P. Morgan and BofA Merrill Lynch acted as the underwriters for the IPO and BMO Capital Markets and Stifel were co-managers. Who are Silk Road Medical's major shareholders? Silk Road Medical's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Wasatch Advisors LP (11.62%), Vanguard Group Inc. (7.41%), TimesSquare Capital Management LLC (1.70%), Acadian Asset Management LLC (0.43%), Sei Investments Co. (0.35%) and BNP Paribas Financial Markets (0.33%). Insiders that own company stock include Andrew S Davis, Andrew S Davis, Elizabeth H Weatherman, Erica J Rogers, Erica J Rogers, Jack W Lasersohn, Kevin J Ballinger, Kevin M Klemz, Lucas W Buchanan, Marie L Jones, Richard Ruedy and Tony M Chou. View institutional ownership trends. How do I buy shares of Silk Road Medical? Shares of SILK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:SILK) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersGuard Against the Coming Financial UpheavalPorter & CompanyElon’s New Device is About to Shock the WorldInvestorPlaceTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressCharles Payne Demystifies OptionsUnstoppable ProsperityThe only AI company you should be looking atBehind the MarketsNo experience to confident trader, meet my student…Wealth Builders InstituteCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Silk Road Medical, Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
